Tag: big pharma

Shingles Vaccine May Increase Risk of Ocular Shingles Recurrence

Getting the recombinant zoster (shingles) vaccine (RZV), or Shingrix, if you have had an ocular shingles event, may increase your risk of experiencing a second event, a recent study shows.

Ocular shingles refers to all shingles that manifest in the eye area. Milder cases of ocular shingles typically occur near the eyelids, while more severe cases may cause inflammation inside the eyes and potentially lead to blindness.

Researchers at the University of California (UC)–San Francisco found that, compared to unvaccinated people with a history of ocular shingles, those who receive the RZV have a 93 percent higher rate of developing ocular shingles again.

“It’s not a huge increased risk,” lead author Dr. Nisha Acharya, director of the Uveitis and Ocular Inflammatory Disease Service at UC–San Francisco, told The Epoch Times. “To my knowledge, it’s the first data that we have on risks of reactivation following zoster vaccination for this patient population who already have the disease. I think it raises some questions,” she said.

Keep reading

Caught Red Handed: Fauci, Gates & Moderna are responsible for the COVID Pandemic – U.S. D.O.D issued a ‘COVID-19 Research’ contract 3 Months before COVID was known to exist – & Fauci & Moderna had a Vaccine ready in Dec. 2019

The discovery of a contract awarded by the U.S. Department of Defense to Labyrinth Global Health for “COVID-19 Research” in November 2019 has raised questions about the permanent U.S. Government’s knowledge of the novel coronavirus.

The contract was part of a larger project for a “Biological threat reduction program in Ukraine,” suggesting the permanent U.S. Government was at the very least aware of the alleged virus before it spread through Wuhan, China in December 2019.

But the findings also suggest the permanent U.S. Government may have had a hand in the creation of this alleged virus in Biolabs through Gain of Function Research overseen by Dr Anthony Fauci.

This would explain why they knew the name of the novel coronavirus disease three months prior to the World Health Organization officially naming it Covid-19 in February 2020.

And it may also explain why Moderna and Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) had a confidentiality agreement for an mRNA Coronavirus vaccine candidate in early December 2019, which was developed and jointly owned by Moderna and Fauci’s NIAID.

Keep reading

TV drug ads are not about selling more pharmaceuticals; they’re about Big Pharma BUYING OFF the media

All those obnoxious pharmaceutical commercials that get laced into just about every television and cable “news” program that airs in the United States these days might seem like they are simply about selling more drugs and getting people hooked, but Big Pharma’s true agenda is actually much more sinister than that.

Former pharmaceutical industry insider Calley Means spoke to Tucker Carlson recently about what he described as an “open secret” within the pharmaceutical industry. In essence, Means says that Big Pharma is buying the media with all those ads, which allows the drug industry to control what gets broadcasted on television and across the internet.

“You’re saying that pharma buys TV spots not to convince people to ask for specific drugs from their physicians, but to subvert the news business?” Carlson asked Means during the segment.

“This is an open secret working for pharma,” Means responded. “The kind of silly ads you see between the news breaks, the point of that is not – it’s largely to impact the customer. But pharma has already got that. They’ve already bought off the doctors. They’re good on that.”

“The news ad spending from pharma is a public relations lobbying tactic, essentially to buy off the news,” Means continued. “They’re not investigating pharma. The news has become basically a referee. That you are a terrible anti-science luddite for asking why the shots that we require our kids to get, that fundamentally by their own advertising change the immune system of that child for life.”

Keep reading

Inside the plan to diagnose Alzheimer’s in people with no memory problems — and who stands to benefit

In a darkened Amsterdam conference hall this summer, a panel of industry and academic scientists took the stage to announce a plan to radically expand the definition of Alzheimer’s disease to include millions of people with no memory complaints.

Those with normal cognition who test positive for elevated levels of certain proteins that have been tied to Alzheimer’s — but not proven to cause the disease — would be diagnosed as having Alzheimer’s Stage 1, the panel members explained.

Even before the presentation ended, attendees in the packed hall were lining up behind microphones to ask questions, according to video of the event.

“I’m troubled by this,” Dr. Andrea Bozoki, a University of North Carolina neurologist, told the panel. “You are taking a bunch of people who may never develop dementia or even cognitive impairment and you’re calling them Stage 1. That doesn’t seem to fit.”

Keep reading

U.S. Military Told Pharma Exec the Virus “Posed a National Security Threat” on February 4th 2020 – Weeks Before a Single Death Occurred

A leaked recording obtained by investigator and writer Sasha Latypova features an executive at the pharmaceutical company AstraZeneca stating the following:

It wasn’t a surprise to me when I got a call on February 4th from the Defence Department here in the U.S. saying that the newly discovered SARS-2 virus posed a national security threat.

This is an astonishing, major-newspaper headline-worthy revelation.

Here’s what was happening on February 4th 2020:

Virus activity in the U.S.:

  • According to CNN, on February 4th there were 11 “confirmed cases of the novel coronavirus” in the United States. 
  • There were zero reported deaths from the virus in the U.S.
  • As documented in my recently launched Covid Timeline Wiki Project, the New York Times had two headlines about the virus focused on China and travellers from Wuhan. There were no op-eds on the virus.

Virus activity internationally:

  • Approximately 490 reported deaths.
  • The disease caused by the virus had not even been named “COVID-19” yet.
  • The WHO said the outbreak “was not yet a pandemic”.

Behind-the-scenes virus-related activity: EUA & PREP Act:

  • Crucially, the FDA and HHS declared the first emergency basis for issuance of Emergency Use Authorisation (EUA) for Covid on February 4th. 
  • EUA is an authority that was granted to the FDA “to strengthen public health protections against biological, chemical, nuclear and radiological agents”.
  • As explained in a previous article, EUA powers were granted to the FDA to be used in situations of grave, immediate emergencies involving weapons of mass destruction. They were intended to allow the use of countermeasures against biological, chemical, nuclear or radiological (CBRN) agents without going through all the usual steps of ensuring safety and efficacy, because the immediate threat of the CBRN attack would be so much greater than any potential risks caused by the countermeasure.
  • In conjunction with EUA, PREP Act protection was also granted retroactively to February 4th (announced March 17th). The Public Readiness and Emergency Preparedness (PREP) Act, as noted in a previous article, legally indemnifies from all liability anyone who does anything related to a product that receives Emergency Use Authorisation. Again, this was intended for very extreme emergency situations involving CBRN agents, so that if a countermeasure caused harm while being used during the attack, no one would get sued.

Origins cover-up:

  • Anthony Fauci, Jeremy Farrar, Francis Collins, Eddie Holmes and others in the international group of gain-of-function funders and researchers were conspiring to publish multiple documents denying the possibility that the virus could have emerged from the virus lab they were funding and working with in Wuhan, China.
  • Emily Kopp at U.S. Right to Know has compiled a detailed timeline of these activities, many of which occurred on the days just before and just after February 4th 2020.

Keep reading

Moderna Scientists Warn mRNA Vaccines Carry Toxicity Risks

The technology used in Moderna’s COVID-19 vaccine carries toxicity risks, scientists with the company said in a new paper.

“A major challenge now is how to efficiently de-risk potential toxicities associated with mRNA technology,” the scientists wrote in the paper, which was published by Nature Reviews Drug Discovery on Jan. 23.

The Moderna and Pfizer COVID-19 shots use modified messenger ribonucleic acid (mRNA) technology. The mRNA is delivered by lipid nanoparticles (LNP).

The toxicity risks include “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs,” the authors of the paper said.

Authors of the paper include Eric Jacquinet and Dimitrios Bitounis, Moderna employees, and Maximillian Rogers, who was working at Moderna when the paper was being done.

Moderna didn’t respond to a request for comment.

The mRNA vaccines have multiple known side effects, including heart inflammation and severe allergic shock. Those may stem from hypersensitivity reactions, which can be elicited by “any LNP-mRNA component” but are most likely triggered by PEGlyated lipid nanoparticles, which is “the most potentially reactogenic component,” the scientists said.

Polyethylene glycol, or PEG, an ingredient in the Pfizer and Moderna COVID-19 vaccines, is known to cause allergic reactions. Outside scientists are divided over the mechanism behind the heart inflammation, while Pfizer has posited that the LNPs are behind the issue.

The new paper drew from prior publications and other data. The authors didn’t carry out any new experiments.

Keep reading

BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine

Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will compare Vaxart’s oral pill vaccine candidate to an approved mRNA (messenger ribonucleic acid) biologic.1 2 3 4

“We are very honored to receive this BARDA award, which will support the innovative approach of our oral pill vaccine platform,” said Michael Finney, PhD, Vaxart’s interim chief executive officer. “We believe our oral pill vaccine platform may ultimately hold the promise of revolutionizing how we fight pandemics and how we vaccinate against several infectious diseases.”2 4

According to Vaxart’s chief medical officer, James Cummings, MD, the company’s oral pill vaccine could improve existing COVID biologics in “two important ways”…

First, a thermostable pill vaccine such as Vaxart’s offers the chance to overcome needle-phobia, a documented obstacle to vaccination, and offers the potential to make it easier to vaccinate more people faster than with traditional injected vaccines. Second, our previous research on other vaccine constructs found Vaxart’s oral pill vaccine to be cross-reactive against all tested SARS-CoV-2 variants and to trigger long-lasting immune responses, potentially offering broader, longer protection than the current first-generation vaccines. We believe our vaccine does this by triggering both a systemic and mucosal response.2 4

Additionally, Vaxart’s oral pill vaccine platform eliminates the need for refrigeration during storage and transportation, allowing more convenience and flexibility to those delivering and administering the drug. It also eliminates the risk of “needle-stick injury.”1 3

Keep reading

A New Pain Medication Could Reinforce the Disastrous Crackdown on Prescription Opioids

Vertex Pharmaceuticals is trumpeting the results of clinical trials indicating that VX-548, its new, non-opioid analgesic, is effective at relieving post-surgical pain. While there is nothing wrong with offering patients and doctors another option for treating acute pain, the Phase 3 trials found that VX-548 was no more effective than a combination of hydrocodone and acetaminophen in relieving pain after tummy tucks and less effective for patients who had bunions removed.

As a new drug under patent, VX-548 is bound to be much more expensive than generic versions of Vicodin, and its main selling point seems to be based on a gross exaggeration of that familiar drug’s addictive potential. The introduction of VX-548 therefore could reinforce myths about the risks of prescription opioids and encourage the government’s misguided and heavy-handed crackdown on those medications.

“People who are suffering from severe pain but don’t want to risk addiction to an opioid are closer to a new option for treatment,” The Wall Street Journal reports. The Journal claims “opioids are highly addictive,” which is not true by any reasonable measure.

A 2018 BMJ study of 568,612 patients who took prescription opioids following surgery found that 5,906, or 1 percent, showed documented signs of “opioid misuse” during the course of the study, which included data from 2008 through 2016. The outcome measure that the researchers used, “opioid dependence, abuse, or overdose,” is a broad category that includes patterns of use falling short of what most people would recognize as addiction. That suggests the actual addiction rate in this study probably was less than 1 percent, although it’s not clear how much less. The authors noted that “overall rates of misuse were low.”

Estimates of addiction rates among patients who take opioids for longer periods of time tend to be higher but still lower than the phrase “highly addictive” suggests. A 2010 analysis in the Cochrane Database of Systematic Reviews found that less than 1 percent of patients taking opioids for chronic pain experienced addiction. A 2012 review in the journal Addiction likewise concluded that “opioid analgesics for chronic pain conditions are not associated with a major risk for developing dependence.”

Keep reading

Medicine Has Been Fully Militarized

Iam thinking of a certain industry. See if you can guess what it is.

This industry is huge, constituting a large portion of the nation’s GDP. Millions of people earn their living through it, directly or indirectly. The people at the top of this industry (who operate mostly behind the scenes, of course) are among the super-rich. This industry’s corporations lobby the nation’s government relentlessly, to the tune of billions of dollars per year, both to secure lucrative contracts and to influence national policy in their favor. This investment pays off richly, sometimes reaching trillions of dollars.

The corporations supplying this industry with its materiel conduct advanced, highly technical research that is far beyond the understanding of the average citizen. The citizens fund this research, however, through tax dollars. Unbeknownst to them, many of the profits gained from the products developed using tax dollars are kept by the corporations’ executives and investors.

This industry addresses fundamental, life-or-death issues facing the nation. As such, it relentlessly promotes itself as a global force for good, claiming to protect and save countless lives. However, it kills a lot of people too, and the balance is not always a favorable one.

The operational side of this industry is emphatically top-down in its structure and function. Those who work at the ground level must undergo rigorous training that standardizes their attitudes and behavior. They must follow strict codes of practice, and they are subject to harsh professional discipline if they deviate from accepted policies and procedures, or even if they publicly question them. 

Finally, these ground-level personnel are handled in a peculiar manner. Publicly, they are frequently lauded as heroes, particularly under declared periods of crisis. Privately, they are kept completely in the dark regarding high-level industry decisions, and they are often lied to outright by those at higher levels of command. The “grunts” even significantly forfeit some fundamental civil liberties for the privilege of working in the industry.

What industry am I describing?

If you answered, “the military,” of course you would be correct. However, if you answered “the medical industry,” you would be every bit as right.

Keep reading

Several Common Drugs Are Linked to Dementia

It is well-known that dementia is often a result of aging. However, sometimes it can be caused by medications.

Drug-induced dementia, the late neurologist and neurosurgeon K.K. Jain wrote, is a type of reversible dementia different from common neurodegenerative disorders.

Several drugs increase the risks of dementia, the most prominent being anticholinergic drugs, anti-epileptics, oncology drugs, and sedative-hypnotic drugs. These are all common prescriptions for older people.

In recent years, antidepressants have also been linked with dementia risks.

Psychiatrist Dr. Peter Breggin, who has published several books on psychopharmacology, told The Epoch Times that most drugs on the market have some degree of neurotoxicity, which can lead to cognitive and neurological side effects.

Not everyone will be affected by a drug’s neurotoxic effects, though older people and those with brain deficits are more vulnerable.

With illnesses that surface in old age and the pills prescribed to treat each symptom, older people also tend to be the most likely cohort to be prescribed drugs that damage their cognition.

Keep reading